AvalehtP8A • SGX
add
Cordlife Group Ltd
Viimane sulgemishind
0,16 $
Aasta vahemik
0,12 $ - 0,23 $
Turuväärtus
41,47 mln SGD
Keskmine maht
105,62 tuh
P/E suhe
-
Dividendimäär
-
Põhibörs
SGX
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (SGD) | dets 2024info | Y/Y muutus |
|---|---|---|
Käive | 9,33 mln | −31,97% |
Põhitegevusega seonduv kulu | 9,18 mln | −4,84% |
Puhastulu | −3,16 mln | −587,67% |
Puhaskasumimarginaal | −33,94 | −817,55% |
Puhaskasum aktsia kohta | — | — |
EBITDA | −2,96 mln | −1 068,74% |
Tõhus maksumäär | −20,52% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (SGD) | dets 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 60,58 mln | −8,24% |
Kogu vara | 217,14 mln | −4,95% |
Kõik kohustused | 98,48 mln | 6,12% |
Kogu omakapital | 118,66 mln | — |
Emiteeritud aktsiate arv | 256,31 mln | — |
Hinna ja väärtuse suhe P/B | 0,35 | — |
Varade tasuvus | −4,62% | — |
Kapitali tasuvus | −8,29% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (SGD) | dets 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | −3,16 mln | −587,67% |
Põhitegevuse rahakäive | −2,70 mln | −224,40% |
Investeeringute raha | −4,31 mln | −938,42% |
Finantseerimise raha | 4,13 mln | 544,30% |
Raha ja raha ekvivalentide muutus | −2,96 mln | −287,36% |
Tasuta rahavoog | −3,02 mln | −1 874,59% |
Teave
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
In January 2018, Cordlife acquired HealthBaby Biotech Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. Wikipedia
Tegevjuht
Asutatud
2. mai 2001
Veebisait
Töötajate arv
111
